Clinical Trial Update: ButOx Human Trial: An Open Label Prospective Cohort Study to Investigate the Effect of Tributyrin (Butyrate Precursor Molecule) Supplementation on Markers of Calcium Oxalate Nephrolithiasis [NA]

View source ↗

Summary

ClinicalTrials.gov update for an open-label prospective cohort study evaluating tributyrin supplementation on markers of urolithiasis/nephrolithiasis; study sta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nephrolithiasis
• Urolithiasis

Drugs mentioned

• Tributyrin (tributyrin)

Snippet

Sponsor: University of British Columbia | Conditions: Urolithiasis | NA | Status: NOT_YET_RECRUITING